SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy’s Q1 consolidated net jumps 27.87%

19 Jul 2012 Evaluate

Dr Reddy’s has reported results for first quarter ended June 30, 2012.

On the standalone basis, the company has posted a fall of 60.87% in its net profit at Rs 177.66 crore for the quarter ended June 30, 2012 as compared to Rs 454.05 crore for the same quarter in the previous year. However, total income has increased by 4.70% at Rs 1834.94 crore for quarter under review as compared to Rs 1752.50 crore for the quarter ended June 30, 2011.

On the consolidated basis, the company has posted a rises of 27.87% in its net profit at Rs 335.98 crore for the quarter ended June 30, 2012 as compared to Rs 262.74 crore for the same quarter in the previous year. Total income has increased by 28.31% at Rs 2562.46 crore for quarter under review as compared to Rs 1997.02 crore for the quarter ended June 30, 2011.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs. 

Dr. Reddys Labs. Share Price

1350.00 21.65 (1.63%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: